Investors Archives - Page 3 of 13 - Scancell

Scancell Financial Year 2026 Interim Results

by chantal | Jan 29, 2026 | Investor Presentations, Investors, Presentations

H126: solid iSCIB1+ data underpins planned progress

by alex | Jan 29, 2026 | Immunobody, iSCIB1+, Moditope, SCIB1, Trinity Delta Reports

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

FDA clears global Phase III trial for iSCIB1+

by alex | Jan 26, 2026 | Immunobody, iSCIB1+, Moditope, SCIB1, Trinity Delta Reports

Welcome to WordPress. This is your first post. Edit or delete it, then start writing!

ESMO IO: Refining Standard of Care in Advanced Melanoma

by chantal | Dec 12, 2025 | Investor Presentations

CEO Phil L’Huillier gives Report on Melanoma trial success to Proactive

by chantal | Dec 12, 2025 | Investor Presentations

SCOPE Data Update: 11 December 2025

by alex | Dec 12, 2025 | Immunobody, Investor Presentations, iSCIB1+, SCIB1

« Older Entries

Next Entries »